Literature DB >> 23359758

Value of c-Met for Predicting Progression of Precancerous Gastric Lesions in Rural Chinese Population.

Yu Sun1, Meng-Meng Tian, Li-Xin Zhou, Wei-Cheng You, Ji-You Li.   

Abstract

OBJECTIVE: To investigate the value of c-Met in predicting progression of precancerous gastric lesions.
METHODS: A population-based study was conducted to detect the overexpression of c-Met by immunohisto- chemical analysis in 124 subjects with precancerous gastric lesions. Odds ratio (OR) and 95% confidence interval (95% CI) were calculated for the association of c-Met overexpression with the risk of advanced gastric lesions.
RESULTS: The positive rates of c-Met were 55.7% in intestinal metaplasia (IM) and 64.8% in dysplasia (DYS), respectively. Stratified analysis indicated that the proportion of c-Met overexpression was 71.4% for IM progressive group, significantly higher than that for IM persistent group (40.0%, P<0.05). Compared to the IM persistent group, unconditional logistic regression showed that OR of c-Met overexpression for the IM progressive group was 7.416 (95% CI: 2.084-26.398).
CONCLUSION: c-Met plays an important role in gastric carcinogenesis. Detection of c-Met is of value in predicting progression of precancerous gastric lesions from IM to DYS.

Entities:  

Keywords:  Dysplasia; Follow-up; Intestinal metaplasia; c-Met

Year:  2012        PMID: 23359758      PMCID: PMC3555253          DOI: 10.1007/s11670-012-0018-x

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  25 in total

1.  Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer.

Authors:  W C You; J Y Li; W J Blot; Y S Chang; M L Jin; M H Gail; L Zhang; W D Liu; J L Ma; Y R Hu; S D Mark; P Correa; J F Fraumeni; G W Xu
Journal:  Int J Cancer       Date:  1999-11-26       Impact factor: 7.396

2.  Carcinoma and intestinal metaplasia of the stomach in Colombian migrants.

Authors:  P Correa; C Cuello; E Duque
Journal:  J Natl Cancer Inst       Date:  1970-02       Impact factor: 13.506

Review 3.  Scatter-factor and semaphorin receptors: cell signalling for invasive growth.

Authors:  Livio Trusolino; Paolo M Comoglio
Journal:  Nat Rev Cancer       Date:  2002-04       Impact factor: 60.716

4.  Activation of the met oncogene in the human MNNG-HOS cell line involves a chromosomal rearrangement.

Authors:  P R Tempest; B R Reeves; N K Spurr; A J Rance; A M Chan; P Brookes
Journal:  Carcinogenesis       Date:  1986-12       Impact factor: 4.944

5.  Progression of precancerous gastric lesions.

Authors:  W C You; L Zhao; Y S Chang; W J Blot; J F Fraumeni
Journal:  Lancet       Date:  1995-04-01       Impact factor: 79.321

6.  Gastric cancer in Colombia. III. Natural history of precursor lesions.

Authors:  P Correa; C Cuello; E Duque; L C Burbano; F T Garcia; O Bolanos; C Brown; W Haenszel
Journal:  J Natl Cancer Inst       Date:  1976-11       Impact factor: 13.506

7.  Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing.

Authors:  G A Rodrigues; M A Naujokas; M Park
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

8.  Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis.

Authors:  T Terada; Y Nakanuma; A E Sirica
Journal:  Hum Pathol       Date:  1998-02       Impact factor: 3.466

9.  [The prognostic significance of expression of c-met oncogene and its relation to gastric mucosal lesions].

Authors:  X Zhuang; J Zheng; S Lin; G Sun; Y Li
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2000-12

10.  Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response.

Authors:  Yuri Churin; Laila Al-Ghoul; Oliver Kepp; Thomas F Meyer; Walter Birchmeier; Michael Naumann
Journal:  J Cell Biol       Date:  2003-04-28       Impact factor: 10.539

View more
  5 in total

1.  miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway.

Authors:  Weiguo Cao; Weiping Yang; Rong Fan; Hao Li; Jinsong Jiang; Mei Geng; Yening Jin; Yunlin Wu
Journal:  Tumour Biol       Date:  2013-09-26

Review 2.  Clinical significance of MET in gastric cancer.

Authors:  Mikito Inokuchi; Sho Otsuki; Yoshitaka Fujimori; Yuya Sato; Masatoshi Nakagawa; Kazuyuki Kojima
Journal:  World J Gastrointest Oncol       Date:  2015-11-15

3.  Lysosomal-associated protein transmembrane 4 Beta-35 overexpression is a novel independent prognostic marker for gastric carcinoma.

Authors:  Luying Liu; Xuefang Xu; Lili Jing; Gengyin Zhou; Zhang Cao; Yanchun Han; Rouli Zhou
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

4.  MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.

Authors:  Jing Zhang; Lei Guo; Xiuyun Liu; Wenbin Li; Jianming Ying
Journal:  Oncotarget       Date:  2017-02-07

5.  [rCsHscB derived from Clonorchis sinensis has therapeutic effect on dextran sodium sulfate-induced chronic ulcerative colitis in mice].

Authors:  H Hua; X Dong; Y Zhang; F Fang; B Zhang; X Li; Q Yu; K Zheng; C Yan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-05-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.